nicolas fulpius
partner
Nicolas Fulpius brings several years of experience in the private equity and venture capital industry. As partner at affentranger associates, he is mainly active with start-up and high growth companies and is involved in several investments as Chairman of the Board including SIRS-Lab, selFrag, inflaRx and Dunes Technologies (sold to VMware). Prior to joining affentranger associates, he was investment director at Ultreia Capital, a venture company focusing on biotech and acted as private equity portfolio manager for the LODH Immunology Fund, a fund specializing in the life sciences industry.
Nicolas Fulpius holds a MBA (HSG lic. oec.) from the University of St. Gall (Switzerland) and a MS in Engineering from Stanford University (USA).
